AXIM BIOTECHNOLOGIES, INC. Additional Collateral, Aggregate Fair Value
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Additional Collateral, Aggregate Fair Value of $814.55 thousand as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments
us-gaap:AdditionalCollateralAggregateFairValue · last filed 2024-08-19
- 2024-06-30: Additional Collateral, Aggregate Fair Value $814.55K.
- 2024-03-31: Additional Collateral, Aggregate Fair Value $814.55K.
- 2024-03-15: Additional Collateral, Aggregate Fair Value $135.63K.
| Period end | Additional Collateral, Aggregate Fair Value |
|---|---|
| 2024-06-30 | $814.55K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $814.55K 10-Q/A · filed 2024-05-22 |
| 2024-03-15 | $135.63K 10-Q · filed 2024-08-19 |